Will omicron-specific booster shots be more effective at combating COVID-19? 5 questions answered

The FDA’s authorization of the reformulated COVID-19 booster shots represents a major step in the effort to get more Americans boosted.

Mitzi Nagarkatti, Professor of Pathology, Microbiology and Immunology, University of South Carolina • conversation
Sept. 1, 2022 ~9 min

Will omicron-specific booster shots be effective at combating COVID-19? 5 questions answered

The FDA’s authorization of the reformulated COVID-19 booster shots represents a major step in the effort to get more Americans boosted.

Mitzi Nagarkatti, Professor of Pathology, Microbiology and Immunology, University of South Carolina • conversation
Sept. 1, 2022 ~9 min


Do you need a second booster shot? An epidemiologist scoured the latest research and has some answers

New data on the second booster suggests the older you are, the more you need it.

Katelyn Jetelina, Assistant Professor of Epidemiology, University of Texas Health Science Center at Houston • conversation
April 13, 2022 ~9 min

COVID-19 vaccines for the youngest children may be inching closer to authorization – a pediatrician explains how they're being tested

Moderna will ask the FDA to allow emergency use for its vaccine in children as young as 6 months, a step many parents have been anticipating.

Debbie-Ann Shirley, Associate Professor of Pediatrics, University of Virginia • conversation
March 30, 2022 ~9 min

Tense decision-making as CDC joins FDA in recommending Pfizer booster shot for 65 & up, people at high risk and those with occupational exposure to COVID-19

Fault lines between the FDA and CDC regulatory processes have been on full display in the decisions over which groups of Americans should receive the Pfizer booster shot.

Matthew Woodruff, Instructor of Human Immunology, Emory University • conversation
Sept. 25, 2021 ~6 min

What happens when the COVID-19 vaccines enter the body – a road map for kids and grown-ups

An infectious disease doctor explains the science behind COVID-19 vaccines at a level that children – and adults – of all ages can understand.

Glenn J Rapsinski, Pediatric Infectious Diseases Fellow, University of Pittsburgh • conversation
Aug. 30, 2021 ~8 min

What does full FDA approval of a vaccine do if it's already authorized for emergency use?

While emergency use authorization gets vaccines out to the public more quickly, it doesn’t skip any steps that full approval requires.

Jennifer Girotto, Associate Clinical Professor of Pharmacy Practice, University of Connecticut • conversation
Aug. 11, 2021 ~5 min

New COVID-19 vaccine warnings don't mean it's unsafe – they mean the system to report side effects is working

Ongoing tracking is meant to spot very rare risks – like the connection between the Johnson & Johnson shot and Guillain-Barré syndrome. And it relies on public reporting.

Justin Vesser, Manager of Ambulatory Pharmacy Services, University of Virginia • conversation
July 19, 2021 ~9 min


Kids aren't just littler adults – here's why they need their own clinical trials for a COVID-19 vaccine

As many teens and adults in the US restart their social lives, parents of children under the age of 12 wonder when their kids will also be able to experience the freedom that comes with vaccination.

Judy Martin, Professor of Pediatrics, University of Pittsburgh • conversation
July 16, 2021 ~10 min

How do mRNA vaccines work – and why do you need a second dose? 5 essential reads

So far, most vaccines in the US are mRNA vaccines. These represent a new technology and are likely to take over the vaccine world. But how do they work? What are their weaknesses? Five experts explain.

Daniel Merino, Assistant Editor: Science, Health, Environment; Co-Host: The Conversation Weekly Podcast • conversation
March 16, 2021 ~6 min

/

3